NASDAQ Healthcare Medical - Care Facilities BTMD

biote Corp.

$ 2.26 -0.44 %

Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.

CEO: Bret Christensen - https://biote.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

$3.25 43.81 %

Recommandation

Buy

DCF

$ 8.67

Loading data...

BTMD vs S&P500

Loading data...

No data available.

Quick ratio

0.58

indicates that the company may have difficulty covering its short-term debts with its readily available assets.

P/E ratio

5.26

may indicate that the company is undervalued or has poor growth prospects.

EPS

0.43

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

-22.91 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

37.12 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

8.52

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

-1.93

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

0.91

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

9.22 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
6 indicates moderate financial health
Altman score
3.18 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.19 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
1.22 indicates that the company has more debt than assets, which could indicate a risky financial situation
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.